BioCement Technologies Receives Small Business Innovation Research Grant

BioCement Technologies Inc. (BTI), high-tech manufacturer of bio-cement, was awarded a Small Business Innovation Research (SBIR) grant through the National Institute of Health for the amount of $53,968 to test bio-cement for bioremediation of heavy metal contaminated soils. Going forward, this will allow BTI to apply for phase II of the SBIR program as well as phase IIB, with potential grant awards of $1 million and up to $3 million in matching of investment funds, respectively.

For more information on the SBIR grant, visit http://sbirsource.com and to learn about BTI, go to www.biocementtech.com.